Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
-

-

 
WKN: A1KBC9 / Name: Cardinal / Stock / Metals & Mining / Small Cap /

Cardinal Resources Ltd. Stock

Pros and Cons of Cardinal Resources Ltd. in the next few years

Pros
?
C******** o* t** e**********
?
S********** s********
?
M***** P*******
Cons
?
B****
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Cardinal Resources Ltd. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Cardinal Resources Ltd. - - - - - - -
Iron Road Ltd 0.000% 0.000% 0.000% -27.273% 300.000% -86.667% -96.748%
Northern Minerals Ltd. -6.710% -8.000% 2.548% -17.857% -5.294% -29.386% -36.863%
Lynas 2.420% -5.587% -21.759% 40.833% 20.714% 109.158% 86.947%

News

Amazon.com Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Gold mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/94faf2bd-99c1-4ea6-b55d-fdcab23c3865.png
Amazon.com Q2 Earnings Call Highlights

Key Points

Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?: https://cdn.content.foolcdn.com/images/1umn9qeh/production/5d5d57f05229d5e553cc6e2f816603ec4ca01b17-1200x800.png?w=800&q=75&fit=max&auto=format
Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?

Can high-flying growth justify a premium valuation, or is a recovered value play the safer bet for 2026? Investors are weighing Eli Lilly and (NYSE:LLY) against Teva Pharmaceutical Industries (NYSE:

2 Dirt Cheap Healthcare Stocks to Buy With $1,000 Right Now: https://g.foolcdn.com/editorial/images/873295/scientist-lab-technician-holding-wafer.jpg
2 Dirt Cheap Healthcare Stocks to Buy With $1,000 Right Now

Shares of Cencora (NYSE: COR) and Stevanato Group (NYSE: STVN) are down more than 17% and 5%, respectively, so far this year. This is despite solid first-quarter earnings and steady business models.